leisure time -WSS

leisure time

author：Wikipedia 2025-08-04 03:39:55 - browse：3828

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

hotspot

WSS

Obamacare plans could cover weight loss drugs

Opioid cravings were reduced by anti

NIH study of ME/CFS points to clear biological hallmarks

Medicare Advantage enrollment hits roughly 33.4 million

WATCH: Why do our ears pop?

6 phony surgeries that take placebo to the extreme

hotspot

leisure time

knowledge

Sports medicine is finally prioritizing gender equality

With competition flaring, obesity drug hits goal in liver disease study

Alkermes shareholders re

Alabama IVF ruling threatens families facing fatal genetic disease

23andMe had bad news about my health. I wish a person had delivered it

As AI regulations shape up, health tech startups beg for clarity

Peter Hotez and the public health issue of online harassment

Opioid cravings were reduced by anti

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Flagship Pioneering startup Sonata Therapeutics lays off 21

hotspot

New study raises questions about niacin and heart health

Obamacare plans could cover weight loss drugs

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Community Health Systems hospitals under DOJ investigation

knowledge

Wikipedia

hotspot

entertainment